Compare EWBC & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EWBC | ZBH |
|---|---|---|
| Founded | 1998 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.7B | 18.7B |
| IPO Year | 1999 | N/A |
| Metric | EWBC | ZBH |
|---|---|---|
| Price | $113.58 | $89.26 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 20 |
| Target Price | ★ $124.42 | $107.00 |
| AVG Volume (30 Days) | 691.5K | ★ 2.3M |
| Earning Date | 01-22-2026 | 02-05-2026 |
| Dividend Yield | ★ 2.11% | 1.08% |
| EPS Growth | ★ 14.57 | N/A |
| EPS | ★ 9.07 | 4.03 |
| Revenue | $2,572,339,000.00 | ★ $8,010,900,000.00 |
| Revenue This Year | $8.44 | $7.99 |
| Revenue Next Year | $7.04 | $5.20 |
| P/E Ratio | ★ $12.52 | $22.10 |
| Revenue Growth | ★ 6.63 | 5.47 |
| 52 Week Low | $68.27 | $85.33 |
| 52 Week High | $117.00 | $114.44 |
| Indicator | EWBC | ZBH |
|---|---|---|
| Relative Strength Index (RSI) | 63.46 | 37.86 |
| Support Level | $112.63 | $90.46 |
| Resistance Level | $117.00 | $92.82 |
| Average True Range (ATR) | 2.62 | 2.09 |
| MACD | 0.26 | -0.24 |
| Stochastic Oscillator | 65.73 | 10.05 |
East West Bancorp Inc operates in U.S. and Asia. The Bank provides range of personal and commercial banking services to individuals and businesses. In addition to offering traditional deposit products that include personal and business checking and savings accounts, money market, and time deposits, the Bank also offers foreign exchange, treasury management and wealth management services. The Bank has three operating segments, (1) Consumer and Business Banking, (2) Commercial Banking and (3) Treasury and Other. The company generates the majority of its revenue from the Commercial banking segment.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.